Effect of levodopa and entacapone treatment on plasma homocysteine level in Parkinson's disease. Pilot study.

被引：0
|
作者：
Nevrly, M. [1 ]
Ressner, P. [1 ]
Nestrasil, I. [1 ]
Vranova, H. [1 ]
Herzig, R. [1 ]
Kanovsky, P. [1 ]
机构：
[1] Palacky Univ, Dept Neurol, Univ Hosp, CR-77147 Olomouc, Czech Republic
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2006年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [21] Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial
    Nyholm, D.
    Johansson, A.
    Lennernas, H.
    Askmark, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (06) : 820 - 826
  • [22] Exploratory analysis of the effect of entacapone on homocysteine levels in Parkinson's disease patients
    Ostrem, JL
    Kang, GA
    Guarnieri, M
    Hubble, J
    Rabinowicz, A
    Bronstein, JM
    MOVEMENT DISORDERS, 2004, 19 : S183 - S183
  • [23] Levodopa and the progression of Parkinson's disease.
    Morgan J.
    Sethi K.D.
    Current Neurology and Neuroscience Reports, 2005, 5 (4) : 261 - 262
  • [24] Adherence with levodopa/carbidopa/entacapone versus levodopa/carbidopa and entacapone as separate tablets in patients with Parkinson's disease
    Delea, Thomas E.
    Thomas, Simu K.
    Hagiwara, May
    Mancione, L.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (07) : 1543 - 1552
  • [25] Levodopa/carbidopa/entacapone for the treatment of early Parkinson's disease: a meta-analysis
    Liao, Xiaoli
    Wu, Nianyue
    Liu, Dongfeng
    Shuai, Bowei
    Li, Shilei
    Li, Ke
    NEUROLOGICAL SCIENCES, 2020, 41 (08) : 2045 - 2054
  • [26] Levodopa/carbidopa and entacapone in the treatment of Parkinson's disease: efficacy, safety and patient preference
    Mueller, Thomas
    PATIENT PREFERENCE AND ADHERENCE, 2009, 3 : 51 - 59
  • [27] Levodopa/carbidopa/entacapone for the treatment of early Parkinson’s disease: a meta-analysis
    Xiaoli Liao
    Nianyue Wu
    Dongfeng Liu
    Bowei Shuai
    Shilei Li
    Ke Li
    Neurological Sciences, 2020, 41 : 2045 - 2054
  • [28] Effect of vitamin B12, folate, and entacapone on homocysteine levels in levodopa-treated Parkinson's disease patients: A randomized controlled study
    Anamnart, Chumpol
    Kitjarak, Ram
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 319 - 319
  • [29] Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients
    Lamberti, P
    Zoccolella, S
    Iliceto, G
    Armenise, E
    Fraddosio, A
    de Mari, M
    Livrea, P
    MOVEMENT DISORDERS, 2005, 20 (01) : 69 - 72
  • [30] Modest increase in plasma homocysteine follows levodopa initiation in Parkinson's disease
    O'Suilleabhain, PE
    Bottiglieri, T
    Dewey, RB
    Sharma, S
    Diaz-Arrastia, R
    MOVEMENT DISORDERS, 2004, 19 (12) : 1403 - 1408
12345